Tokyo, Aug. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062680) titled 'Evaluation of the safety of intake of a nutraceutical containing highly concentrated S-1-propenyl-L-cysteine (S1PC) extract powder and NMN' on Aug. 25.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Tokyo Midtown Clinic
Midtown Clinic Medical Corporation
Condition:
Condition - Healthy individuals
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the safety of intake of the product containing a high concentration of S1...